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DIFFERENTIATION BETWEEN Nocardia spp. AND Mycobacterium spp.:  
CRITICAL ASPECTS FOR BACTERIOLOGICAL DIAGNOSIS
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SUMMARY
New methodologies were developed for the identification of Nocardia but the initial diagnosis still requires a fast and accurate 
method, mainly due to the similarity to Mycobacterium, both clinical and bacteriologically. Growth on Löwenstein-Jensen (LJ) medium, 
presence of acid-fast bacilli through Ziehl-Neelsen staining, and colony morphology can be confusing aspects between Nocardia and 
Mycobacterium. This study describes the occurrence of Nocardia spp. in a mycobacterial-reference laboratory, observing the main 
difficulties in differentiating Nocardia spp. from Mycobacterium spp., and correlating isolates with nocardiosis cases. Laboratory 
records for the period between 2008 and 2012 were analyzed, and the isolates identified as Nocardia sp. or as non-acid-fast filamentous 
bacilli were selected. Epidemiological and bacteriological data were analyzed as well. Thirty-three isolates identified as Nocardia 
sp. and 22 as non-acid-fast bacilli were selected for this study, and represented 0.12% of isolates during the study period. The 
presumptive identification was based on macroscopic and microscopic morphology, resistance to lysozyme and restriction profiles 
using the PRA-hsp65 method. Nocardia spp. can grow on media for mycobacteria isolation (LJ and BBL MGITTM) and microscopy 
and colony morphology are very similar to some mycobacteria species. Seventeen patients (54.8%) were reported and treated for 
tuberculosis, but presented signs and symptoms of nocardiosis. It was concluded that the occurrence of Nocardia sp. during the study 
period was 0.12%. Isolates with characteristics of filamentous bacilli, forming aerial hyphae, with colonies that may be pigmented, 
rough and without the BstEII digestion pattern in PRA-hsp65 method are suggestive of Nocardia spp. For a mycobacterial routine 
laboratory, a flow for the presumptive identification of Nocardia is essential, allowing the use of more accurate techniques for the 
correct identification, proper treatment and better quality of life for patients.
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INTRODUCTION
Nocardia species are saprophyte aerobic actinomycetes, distributed 
in water, soil, dust, and decaying vegetation worldwide, which may 
occasionally cause disease1,24. Immunosuppression is an important risk 
factor for human nocardial disease, and pulmonary nocardiosis is the most 
common presentation2,14. Cutaneous disease also occurs, through which 
Nocardia may disseminate, mainly in AIDS patients, causing lung and 
central nervous system (CNS) diseases16,21. The mortality rate in patients 
with disseminated disease is high, and alcoholism is a risk factor in the 
dissemination to the CNS17. 
Diagnosis is challenging as clinical and radiographic findings are 
not specific and microbiological identification may be difficult24. The 
laboratory diagnosis is based on microscopy and culture isolation, 
but Nocardia can be mistaken for Mycobacterium, as they not only 
grow in specific media for mycobacteria, but also form partially acid-
fast beaded branching filaments, similar to those formed by rapidly 
growing mycobacteria18. Only experts can differentiate Nocardia from 
Mycobacteria filamentous branches8,18. Moreover, it is difficult to 
identify Nocardia only by phenotypic methods because recent taxonomic 
changes have not been included in the existing schemes5,22. Therefore, 
molecular methods have been used to identify these agents. This study 
describes the occurrence of Nocardia spp. in a mycobacterial-reference 
laboratory, focusing on the main difficulties in differentiating Nocardia 
from Mycobacterium, and correlating isolates with nocardiosis cases. 
MATERIAL AND METHODS
This study was conducted to analyze retrospectively the results from 
isolates sent to the Tuberculosis and Mycobacteriosis Branch of the 
Adolfo Lutz Institute (NTM-IAL), São Paulo, Brazil, for mycobacteria 
identification. NTM-IAL only receives isolates from the State of São 
Paulo. Records from 2008 to 2012 were analyzed and the data was 
stored in a Microsoft Excel spreadsheet. Isolates were classified into two 
groups, 1) isolates identified as Nocardia sp. and 2) isolates presumptively 
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identified as Nocardia, based on the presence of non-acid-fast branching 
filamentous bacilli. Epidemiological data, such as date of notification, 
closing date, reason for closure, HIV testing results, comorbidities and 
clinical evaluation of patients were obtained from TBWEB, the electronic 
notification system of the Center for Epidemiological Surveillance of 
Tuberculosis of the State of São Paulo (CVE-TB).
Isolates were grown on Löwenstein-Jensen (LJ), Sabouraud agar, 
and BBL MGITTM (Becton Dickinson) media, and identified by colony 
morphology (pigment production and colony aspects), microscopic 
characteristics after Ziehl-Neelsen staining, and resistance to lysozyme. 
Lysozyme resistance was determined by inoculating a standardized 
culture suspension into two glycerol broth tubes, one with (test tube) 
and the other without (control tube) a 50 µg/mL lysozyme. Tubes were 
incubated at 35 ºC and examined weekly for four weeks4. An isolate was 
considered as lysozyme resistant when equivalent growth appeared in 
both tubes. Isolates were also submitted to the PRA-hsp65 method as 
described by CHIMARA et al.11. 
This study was approved by the ethical committee of Adolfo Lutz 
Institute under number 072D-2010. 
RESULTS
During the study period, NTM-IAL identified 27,804 isolates. Group 
1 was composed of 33 (0.12%) Nocardia sp. isolates from 31 patients, 
obtained from sputum (20), corneal scrapings (2), abscess secretion (1), 
tracheal aspirate (1), pleural fluid (1), cerebrospinal fluid (1) and not 
discriminated (7). Group 2 was composed of 23 (0.08%) isolates, one per 
patient, obtained from sputum (17), blood (1) and not discriminated (5).
Microbiological aspects. In group 1, all isolates presented branching 
filaments (Fig. 2) and lysozyme resistance, wet colonies on LJ medium, 
showing a salmon (30 isolates) or yellow (3) color (Fig. 1A). Salmon-
colored colonies presented a white aspect after three weeks on Sabouraud 
agar (Fig. 1B), very similar to fungi growth. Growth on BBL MGITTM 
media presented flocculated colonies similar to M. tuberculosis, but 
pigmented (Fig. 1C). The 33 isolates showed no restriction site for the 
BstEII enzyme and undescribed restriction patterns with the HaeIII by 
PRA-hsp65 method. In group 2, all isolates were shown to be filamentous 
bacilli on microscopy and none presented restriction site for the BstEII 
(Fig. 3). Lysozyme test was not performed on those isolates. 
Clinical and epidemiological characteristics. In group 1, 25 
(80.6%) of the 31 patients were male, mean age of 44.1 years (SD 
14.8). All had multiple comorbidities such as arthritis, silicosis, chronic 
pulmonary obstructive disease, smoking, alcohol and some were illicit 
drug users. Seventeen patients (54.8%) were notified to CVE-TB as 
tuberculosis (TB) cases and have therefore been treated for TB. Two 
of them were HIV positive. Eleven patients (68.8%) were cured after 
drug treatment for TB, but three relapsed and three died. Among these 
patients, 10 underwent chest radiography and/or computed tomography. 
Three of them had cavities in the lung parenchyma; in the other seven, 
some suggestive signs of disease activity (consolidation, nodules, 
masses, bronchial wall thickening or “tree-in-bud” aspect) were reported. 
Nocardia sp. was isolated twice from two patients, one with aortic valve 
implantation history, and the other with a history of ocular surgery. During 
this study, CVE-TB intervened in the treatment of two patients who had 
been receiving antituberculosis drugs for six months. In the study period, 
M. tuberculosis from two patients and M. kansasii from one patient were 
also recovered in the same year as the Nocardia was isolated from them.
Among the 22 patients of group 2, 16 (72.7%) were male, mean age of 
41.6 (SD 20.5). Of these, 14 (63.3%) were reported to CVE-TB and after 
TB treatment, nine (64.3%) were cured, two abandoned, one relapsed, one 
had the diagnosis changed, and one died. M. tuberculosis had previously 
been isolated from two patients, and from another individual, a Nocardia 
sp. isolate had also been recovered.
DISCUSSION
The initial diagnosis of nocardiosis requires fast and accurate 
methodology, mainly due to the clinical aspects and bacteriologic 
similarity to the genus Mycobacterium5. McNEIL & BROWN18 
highlighted the importance of direct microscopic examination because, 
despite the new methodologies developed, there is no test replacing it.
Fig. 1 - Macroscopic growth of Nocardia sp. in: A) Lowenstein Jensen medium, B) Agar 
Sabouraud and C) Bactec MGIT medium.
Fig. 2 - Microscopic appearance of Nocardia spp. isolates by Ziehl Neelsen staining. 100x 
increased.
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In this study, 33 isolates and 17 cases of nocardiosis in a five-year 
period were found. Nocardia spp. isolation accounted for 0.12% of all 
isolates identified by NTM-IAL, from 2008 to 2011. HELAL et al.15 
studied 200 sputum samples from patients diagnosed as pulmonary TB 
in Egypt, based on clinical symptoms, chest X-ray and direct smear test 
by acid-fast staining method. Four (2.0%) of these were PCR positive 
for 16S rRNA primer specific for Nocardia, a higher percentage than the 
one obtained in this study. Despite the presence of Nocardia detected 
by PCR, HELAL et al.15 could not obtain growth on LJ. Although the 
literature shows the need for special culture media17, isolates of Nocardia 
spp. received by NTM-IAL showed good growth on LJ medium, as well 
as on other media used for isolation of mycobacteria (Fig. 1). Colony 
morphology on LJ from many species of Nocardia may be confused 
with Mycobacterium species, making diagnosis difficult. Moreover, 
microscopic analysis should be carefully performed, because, as these 
two genera may present ramifications18, Nocardia may be misidentified 
as mycobacteria13 in the routine diagnosis of TB. The differentiation is 
performed by observation of aerial hyphae, produced only by species of 
the genus Nocardia18. Change in cell morphology of Nocardia depending 
on the age of the culture may also lead to misidentification. Young 
cultures exhibit branched-long filaments, while old cultures present 
bacilli and cocci originating from fragmentation of filaments, which 
can be considered mycobacteria bacilli for non-expert microscopists. 
Despite the Ziehl Neelsen method having been used for strong acid fast 
bacteria, such as the Mycobacterium species, and the modified Ziehl 
Neelsen method for weak acid fast bacteria, such as the Nocardia species, 
this study detected the Nocardia by the Ziehl Neelsen method used for 
mycobacteria. This fact shows the importance of an expertise reading, 
since both genera can be detected.
Many studies have shown that phenotypic methods are not accurate 
for Nocardia identification and the need for molecular methods is 
a reality1,5,19. BAIO et al.3 identified seven isolates by 31 different 
phenotypic tests and analyzed profiles using six identification systems. 
Two isolates were identified as Nocardia sp., because a common outcome 
was not found using different schemes. Only two isolates were correctly 
identified by phenotypic identification, compared to the MLSA results. 
Although phenotypic identification produces misidentifications, it can 
improve molecular identification since some molecular targets can present 
high sequence similarity12.
PRA-hsp65 method13 is routinely used at NTM-IAL to amplify a 
440 pb gene fragment that encodes a protein of 65 kDa for mycobacteria 
and actinomycetes9. As Nocardia lack the BstEII restriction site, this 
feature can be used in the presumptive identification of the genus. 
Additionally, Nocardia HaeIII patterns are different to the algorithm 
described by CHIMARA et al. 11.
This study showed three cases of mixed infection by different 
Nocardia and mycobacteria species in immunocompetent patients. A 
similar situation was described at the Baystate Medical Center, MA, 
USA, where bacteriological analysis revealed the presence of mixed 
cultures of N. asteroides and M. tuberculosis7 in two patients with clinical 
TB. The authors of this study showed the importance of bacteriological 
investigation in cases of treatment failure, because it may indicate that the 
patient harbors another agent that is not being addressed, also observed 
in the present study. Other cases of mixed infection by these two genera 
have been reported in immunocompromised patients10,20.
The finding of Nocardia should not be considered contamination and 
the case should be investigated23. In our study, 17 patients had some kind 
of comorbidity (silicosis, smoking, alcohol abuse) or immunosuppression, 
characterizing this group as high risk for nocardiosis23. 
Mycobacteriosis and nocardiosis treatments are different, so the 
correct identification of the agent is essential to avoid ineffective 
therapy15. Initially, all notified patients were treated as TB, but for 31.2% 
of them, treatment was not effective. In these cases, the failure of TB 
treatment was evaluated and new clinical, radiological and bacteriological 
exams were performed to establish the cause of failure. However, 
Nocardia isolation was not taken into consideration and some patients 
were characterized as TB relapse cases. 
In Brazil, TB patients to be considered cured should have, at least, 
two negative smears during the follow-up phase and one more after 
treatment of the disease. In this survey, all patients with prior treatment 
for TB had this criterion6. Pulmonary nocardiosis should be considered 
as differential diagnosis when TB fails to respond with standard therapy, 
or if the patient’s condition worsens despite adequate therapy. 
The isolates of group 2 were only presumptively identified as 
Nocardia sp., a limitation of the study, and possibly they are Nocardia 
or even another actinomycete. An alternative to solve the identification 
can be sequencing the 16SrRNA region. BHARADWAJ et al.5, by 
sequencing organisms with ambiguous phenotypes, was able to identify 
different actinomycetes recovered from clinically significant specimens.
Therefore ,  pat ients  with  a  his tory of  comorbidi t ies , 
immunosuppression, whose isolates present rough, pigmented colonies 
of filamentous aerial hyphae forming bacilli, resistant to lysozyme and 
Fig. 3 - Molecular pattern of Nocardia spp. isolates digested by BstEII restriction enzyme. 
M: 50 bp molecular size marker.
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without the restriction site for BstEII, are suggestive of having Nocardia 
spp. infection. In a mycobacterial-routine laboratory, an algorithm for 
genera and species identification of isolates suggestive of Nocardia spp. 
is essential for the correct diagnosis, which assists in providing adequate 
and early treatment for patients.
RESUMO
Diferenciação de Nocardia spp. e Mycobacterium spp.: aspectos 
críticos para o diagnóstico bacteriológico
Novas metodologias têm sido desenvolvidas para a identificação 
de Nocardia spp. mas o diagnóstico inicial ainda necessita de método 
rápido e preciso, principalmente devido à similaridade com o gênero 
Mycobacterium, clínica e bacteriologicamente. O crescimento em meio 
de Löwenstein Jensen (LJ), a presença de bacilos corados pela coloração 
de Ziehl Neelsen e colônias com características diferentes podem 
ser fatores de confusão entre nocardias e micobactérias. Este estudo 
descreve a ocorrência de Nocardia spp. em laboratório de referência 
em micobacteriologia, observando-se as principais dificuldades em 
diferenciar Nocardia spp. e Mycobacterium spp., correlacionando 
isolados com casos de nocardiose. Os registros laboratoriais dos 
anos 2008 a 2012 foram analisados e os isolados identificados como 
Nocardia sp. ou como bacilos não álcool - ácido resistentes (NBAAR) 
foram selecionados. Os dados epidemiológicos e bacteriológicos foram 
analisados. Trinta e três isolados identificados como Nocardia sp. e 22 
como NBAAR foram selecionados para este estudo, perfazendo 0,12% 
do total de isolados identificados no período estudado. A identificação 
presuntiva foi baseada na morfologia macroscópica e microscópica, 
resistência à lisozima e perfis de restrição pelo método PRA-hsp65. 
Nocardia spp. pode crescer em meios de isolamento para micobactérias 
(LJ e BBL MGITTM) e microscopia de morfologia e as colônias são muito 
semelhantes a algumas espécies de micobactérias. Dezessete pacientes 
(54,8%) foram notificados e tratados para tuberculose, mas apresentaram 
sinais e sintomas para nocardiose. Concluimos que a ocorrência de 
Nocardia sp. no período estudado foi de 0,12%. Os isolados com 
características de bacilos filamentosos, formadores de hifas aéreas, com 
colônias que podem ter pigmento, rugosas e que não possuem padrão de 
digestão para BstEII no método PRA-hsp65 são sugestivos de Nocardia 
spp. Para um laboratório de rotina de Micobactérias, um fluxo de 
identificação presuntiva para Nocardia spp. é essencial para permitir que 
esses isolados sejam identificados com técnicas mais precisas, para que 
seja oferecido o tratamento adequado e qualidade de vida aos pacientes.
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